Menu
ETF
Annual · values202520242023202220212020201920182017201620152014
Operating Cash Flow11.39 M USD9.07 M USD1.31 M USD-686000 USD3.08 M USD4.20 M USD2.59 M USD2.44 M USD1.19 M USD2.17 M USD2.78 M USD2.06 M USD
Depreciation & Amortization1.04 M USD789000 USD550000 USD503000 USD477000 USD616468 USD804587 USD676426 USD636709 USD616021 USD613304 USD567341 USD
Stock-Based Compensation3.06 M USD1.69 M USD708000 USD976000 USD1.02 M USD901932 USD924071 USD862674 USD479482 USD222763 USD110350 USD82228 USD
Capital Expenditures262000 USD287000 USD1.65 M USD1.43 M USD287000 USD844226 USD1.33 M USD526227 USD618763 USD534944 USD523185 USD895177 USD
Cash Flow from Investing-306000 USD-395000 USD-1.72 M USD-1.52 M USD-448000 USD-977196 USD-1.39 M USD-571777 USD-687148 USD-579521 USD-624507 USD-935799 USD
Cash Flow from Financing-11.88 M USD36000 USD-380000 USD-1.52 M USD-1.22 M USD-548030 USD-851152 USD11712 USD-53619 USD-62267 USD-61169 USD-127724 USD
Dividends Paid
Stock Buybacks10.00 M USD275000 USD153000 USD1.45 M USD1.12 M USD
Free Cash Flow11.13 M USD8.78 M USD-333000 USD-2.11 M USD2.79 M USD3.35 M USD1.26 M USD1.92 M USD572358 USD1.63 M USD2.26 M USD1.17 M USD

Electromed Inc. is a leading manufacturer and distributor of medical devices, primarily focusing on respiratory therapy solutions. The company is renowned for its development of innovative airway clearance products, particularly the SmartVest Airway Clearance System, which assists patients with impaired breathing due to conditions like cystic fibrosis, bronchiectasis, and neuromuscular disorders. Electromed Inc. operates mainly within the healthcare sector, providing advanced solutions that improve patient outcomes and enhance quality of life for individuals with chronic respiratory conditions. The company's commitment to research and development helps it maintain a competitive edge, ensuring its products are at the forefront of medical technology. Electromed Inc.'s significant role in the market is underscored by its focus on expanding accessibility to its medical devices, through strategic partnerships and health care provider networks, thereby reinforcing its presence and influence in the respiratory care segment.